Abstract
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is spreading as a pandemic in 2020. Few reports on infections in thoracic transplantation have been published so far. We present a case of COVID-19 in a 55-year old female lung transplant recipient infected 5 months posttransplant, who additionally was co-infected with a Norovirus. Respiratory and gastrointestinal symptoms were observed without need of therapeutic escalation except for antibiotic therapy. We observed a moderate disease evolution likely due to triple immunosuppression.
Highlights
In late 2019, a novel coronavirus, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged from Wuhan, China [1]
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is spreading as a pandemic in 2020
We present a case of COVID-19 in a 55-year old female lung transplant recipient infected 5 months posttransplant, who was co-infected with a Norovirus
Summary
In late 2019, a novel coronavirus, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged from Wuhan, China [1]. This virus leads to the coronavirus disease 2019 (COVID-19), currently causing a pandemic with worldwide severe economic and healthcare consequences [2]. The SARS-CoV-2 infection binds to human host cell receptors, using human angiotensin-converting enzyme 2 (hACE2), there are more factors influencing susceptibility to infection and disease progression. We present a case of COVID-19 in a lung transplant (LTX) recipient presenting with fever and gastrointestinal symptoms in our emergency department
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
